Clinical Trial Update: Safety and Efficacy Study of Aztreonam for Inhalation Solution (AZLI) in Patients With Cystic Fibrosis and Chronic Burkholderia Species Infection [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating safety and efficacy of Aztreonam for inhalation solution (AZLI) in cystic fibrosis patients with chronic Burkholderia spp. infection; r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Burkholderia Cepacia Infection
• Cystic Fibrosis

Drugs mentioned

• Cayston (aztreonam lysine)

Snippet

Sponsor: Gilead Sciences | Conditions: Cystic Fibrosis, Burkholderia Infections | Phase 3 | Status: COMPLETED | Results posted: 2014-03-11